University of California San Francisco
Give to UCSF
A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.
A new study shows how minority patients are effectively disqualified from receiving the latest cystic fibrosis drugs approved only for people with mutations more common among white patients.
UCSF scientists have discovered a new way to control the immune system’s “natural killer” cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection.
A UCSF clinical psychologist has taken aim at the NFL for “race-norming” Black players diagnosed with dementia, a practice that is depriving them of the monetary awards allocated to former footballers with neurodegenerative disorders.
Experts now believe it’s most effective to treat the whole family when traumas occur. UCSF researchers plan to develop a “Whole Family Wellness” intervention that integrates resources from Medi-Cal clinics with outside agencies and test it over a three-year period.
COVID-19 infections are once again rising at an alarming rate in San Francisco’s Latinx community, predominantly among low-income essential workers, according to results of a massive community-based testing blitz conducted before and after the Thanksgiving holiday.
Immunotherapies are a promising anticancer arsenal and work by mobilizing the immune system to recognize and destroy cancer cells. Currently, however, only a third of patients respond to
The imaging technique for prostate cancer locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
A new, $9 million grant from the National Cancer Institute to increase ethnic diversity will help the study work toward a goal of enrolling 100,000 or more women overall.
California’s Black and Hispanic communities may be falling further behind whites in the quality of care they receive for heart attacks, despite recent medical efforts aimed at improving the standards of care for these populations, according to a new study led by researchers at UC San Francisco.
